Researchers have found that the investigational anticoagulant rivaroxaban, given after knee surgery, showed significantly better efficacy and equivalent safety compared with enoxaparin, according to a report in MedPage Today.
Oncology
A recent study published in The Cochrane Library found that weight-loss surgery is effective on those patients with less-severe obesity, but questions still remain about long-term outcomes and which procedures are more effective than others, according to a report in…
Lawmakers in Nevada are challenging the Las Vegas-based University Medical Center's decision to end outpatient cancer treatment at its facility, according to a report in the Las Vegas Sun.
According to Derek Raghavan, MD, director of the Taussig Cancer Institute in Cleveland, “a top cancer center needs to have a fusion of its clinical programs with its experimental and social support programs.” It takes physicians, researchers and staff working…
Cancer treatment is evolving rapidly, which presents both opportunities and challenges to hospitals seeking to maintain or expand their oncology services. Healthcare experts say cancer treatment, spurred by improvements in technology, better drugs and reimbursement changes, is increasingly leaving hospitals…
Advertisement
Medtronic has signed agreements to acquire CoreValve and Ventor Technologies, according to Medtronic news releases.
According to Derek Raghavan, MD, director of the Taussig Cancer Institute in Cleveland, "a top cancer center needs to have a fusion of its clinical programs with its experimental and social support programs." It takes physicians, researchers and staff working…
Hospital-based oncology services, long a mainstay business line, face many challenges as some of those services migrate from hospitals to outpatient surgery centers, physician offices and even to patient homes. Newer drugs, safer surgical procedures and advanced imaging and radiation…
Minneapolis-based medical device manufacturer Medtronic announced it will buy cardiac catheter firm Ablation Frontiers of Carlsbad, Calif., a privately-held device maker specializing in atrial fibrillation products, according to a Medtronic news release.
Despite the promise of minimally invasive joint replacement, recent studies indicating potentially higher rates of surgeon mistakes and complications are raising doubts about efficacy compared with that of open repair, reports the Wall Street Journal. "A study of 80 knee…